FDA.reportPublic FDA data

Application 203135

Type
ANDA
Sponsor
INVAGEN PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CALCIUM ACETATECALCIUM ACETATECAPSULE;ORAL667MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0615-8364Calcium AcetateCalcium AcetateNCS HealthCare of KY, Inc dba Vangard LabsANDACurrent
17856-0377Calcium AcetateCalcium AcetateAtlantic Biologicals CorpsANDACurrent
31722-377Calcium AcetateCalcium AcetateCamber Pharmaceuticals, Inc.ANDACurrent
53808-1001Calcium AcetateCalcium AcetateState of Florida DOH Central PharmacyANDACurrent
53808-1103Calcium AcetateCalcium AcetateDOH CENTRAL PHARMACYANDACurrent
69097-862Calcium AcetateCalcium AcetateCipla USA Inc.,ANDACurrent
69097-862Calcium AcetateCalcium AcetateCipla USA Inc.,ANDACurrent
69097-862Calcium AcetateCalcium AcetateCipla USA Inc.,ANDACurrent
69097-862Calcium AcetateCalcium AcetateCipla USA Inc.,ANDACurrent
71335-0529Calcium AcetateCalcium AcetateBryant Ranch PrepackANDACurrent
71335-0529Calcium AcetateCalcium AcetateBryant Ranch PrepackANDACurrent
71335-0529Calcium AcetateCalcium AcetateBryant Ranch PrepackANDACurrent
76282-377Calcium AcetateCalcium AcetateExelan Pharmaceuticals, Inc.ANDACurrent
76282-377Calcium AcetateCalcium AcetateExelan Pharmaceuticals, Inc.ANDACurrent
76282-377Calcium AcetateCalcium AcetateExelan Pharmaceuticals, Inc.ANDACurrent